Synapticure, a virtual care company focusing on neurodegenerative diseases, has raised $25 million in Series A funding to expand its services and partnerships. The Chicago-based company offers virtual access to neurologists, treatments, and care coordination services for diseases like Alzheimer’s, Parkinson’s, and ALS. The funding, led by B Capital, will be used to enhance AI-powered diagnostics, remote monitoring, and access to emerging treatments and trials. With the rising prevalence of neurodegenerative diseases and a shortage of neurologists, Synapticure aims to provide fast and expert care through its virtual platform, ultimately redefining how these conditions are managed.
Source link
Synapticure Secures $25M To Scale Virtual Care for Neurodegenerative Diseases
